- Home
- GIGM vs LYRA Comparison
GIGM vs LYRA Comparison
Compare GIGM & LYRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GIGM
- LYRA
- Stock Information
- Founded
- GIGM 1998
- LYRA 2005
- Country
- GIGM Taiwan
- LYRA United States
- Employees
- GIGM N/A
- LYRA N/A
- Industry
- GIGM Computer Software: Programming Data Processing
- LYRA Medical/Dental Instruments
- Sector
- GIGM Technology
- LYRA Health Care
- Exchange
- GIGM Nasdaq
- LYRA Nasdaq
- Market Cap
- GIGM 17.9M
- LYRA 15.0M
- IPO Year
- GIGM 2000
- LYRA 2020
- Fundamental
- Price
- GIGM $1.39
- LYRA $8.81
- Analyst Decision
- GIGM
- LYRA Buy
- Analyst Count
- GIGM 0
- LYRA 2
- Target Price
- GIGM N/A
- LYRA $16.00
- AVG Volume (30 Days)
- GIGM 29.6K
- LYRA 618.8K
- Earning Date
- GIGM 07-30-2025
- LYRA 08-13-2025
- Dividend Yield
- GIGM N/A
- LYRA N/A
- EPS Growth
- GIGM N/A
- LYRA N/A
- EPS
- GIGM N/A
- LYRA N/A
- Revenue
- GIGM $3,103,000.00
- LYRA $1,185,000.00
- Revenue This Year
- GIGM N/A
- LYRA N/A
- Revenue Next Year
- GIGM N/A
- LYRA $1,286.17
- P/E Ratio
- GIGM N/A
- LYRA N/A
- Revenue Growth
- GIGM N/A
- LYRA N/A
- 52 Week Low
- GIGM $1.26
- LYRA $3.81
- 52 Week High
- GIGM $1.80
- LYRA $37.50
- Technical
- Relative Strength Index (RSI)
- GIGM 43.40
- LYRA 43.39
- Support Level
- GIGM $1.41
- LYRA $8.35
- Resistance Level
- GIGM $1.45
- LYRA $14.88
- Average True Range (ATR)
- GIGM 0.05
- LYRA 1.47
- MACD
- GIGM -0.00
- LYRA -0.82
- Stochastic Oscillator
- GIGM 9.62
- LYRA 5.18
About GIGM GigaMedia Limited
GigaMedia Ltd is a publisher of online games. It has only one reportable segment, Digital Entertainment service. Digital Entertainment service business operates a portfolio of online games, mainly targeting online game players across Europe, and Asia, including Greater China and Southeast Asia. The company's portfolio of online games includes predominantly PC-based, non-cash gambling, or casino casual games, including MahJong and various card and table games. The company's product lines include MahJong, AkaSeka, Yume 100, Fun Vegas, and others. The company operates in Taiwan and Hong Kong.
About LYRA Lyra Therapeutics Inc.
Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients. The Company's operations and manages its business as a single operating segment which is the business of developing targeted medicines to address ears, nose, and throat, or ENT diseases. Its initial product candidates, LYR-210 and LYR-220, are bioabsorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver continuous drug therapy to the sinonasal passages for the treatment of chronic rhinosinusitis, or CRS.